Boiron SA (BOIRF)

Market Cap	532.45M +17.5%
Revenue (ttm)	588.36M +2.8%
Net Income	38.33M +188.0%
EPS	2.21 +188.0%
Shares Out	n/a
PE Ratio	13.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Open	31.50
Previous Close	n/a
Day's Range	31.50 - 31.50
52-Week Range	24.00 - 32.28
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive l...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,499
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOIRF

Financial Performance

In 2025, Boiron's revenue was 501.11 million, an increase of 2.78% compared to the previous year's 487.56 million. Earnings were 32.64 million, an increase of 187.96%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 17, 2026

Data Sources Report a data error